General Information of the Compound
Compound ID |
CP0147048
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(3R)-8-chloro-3-(pyridin-2-ylmethyl)-4-[[4-([1,2,4]triazolo[1,5-a]pyridine-8-carbonyl)phenyl]methyl]-1,3-dihydro-1,4-benzodiazepine-2,5-dione
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C29H21ClN6O3
|
||||||||||||||||||
Molecular Weight |
536.979
|
||||||||||||||||||
Canonical SMILES |
Clc1ccc2c(NC(=O)[C@@H](Cc3ccccn3)N(Cc3ccc(cc3)C(=O)c3cccn4ncnc34)C2=O)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C29H21ClN6O3/c30-20-10-11-22-24(14-20)34-28(38)25(15-21-4-1-2-12-31-21)35(29(22)39)16-18-6-8-19(9-7-18)26(37)23-5-3-13-36-27(23)32-17-33-36/h1-14,17,25H,15-16H2,(H,34,38)/t25-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
IRKYZWPEKOVHIE-RUZDIDTESA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound